Wound care

Study showing that Mepitel Film prevents radiotherapy skin reactions becomes news

By: Mölnlycke Health Care, April 16 2014Posted in: Wound care

Radiation-induced skin reactions occur in 80-90 percent of breast cancer patients1 and can range from mild redness to ulceration, with symptoms of pain, burning and itchiness. This can have a very negative impact on day-to-day life for patients, who already have to cope with being diagnosed with and treated for cancer.  

However, a study2 conducted in New Zealand has shown that the use of Mepitel® Film, a thin, transparent dressing using Mölnlycke Health Care's Safetac® technology, before, during and after radiation therapy, prevents the development of moist desquamation and reduces the severity of other skin reactions.

Seventy-eight patients undergoing radiation therapy for breast cancer took part in the trial. Each patient’s irradiated skin area was divided into two halves, with Mepitel Film used on one side and aqueous cream on the other. The study found that there were no cases of ulceration or severe skin reactions on the skin under Mepitel Film, whilst cream-treated skin developed these wounds in 26 percent of patients. In addition, the skin reactions that did develop under Mepitel Film were 92 percent less severe than in the cream-treated control group.

These conclusive findings were picked up by TVNZ ONE News and broadcast as a feature news item in their nightly news bulletin. The story mainly focused on the study's core fundamental: that when Mepitel Film is used from the very first day of treatment, skin reaction's severity is reduced by 92 percent. The full news item can be seen here.

References:

  1. Wells M (2003) Radiation skin reactions. Faithfull S (Ed) Supportive care in radiotherapy. London: Churchill Livingstone 135-159.
  2. Herst PM et al. Prophylactic use of Mepitel Film prevents radiation-induced moist desquamation in an intra-patient randomised controlled clinical trial of 78 breast cancer patients. Radiother Oncol (2014) (link opens in a new window).
Share this

More from the same category

Mextra Superabsorbent

Our new Superabsorbent Wound care dressing is here! Its design is based on a unique 4-layer construction...

Meet us at EWMA 23-25 May 2012 in Vienna

We exhibit at EWMA as Corporate A Sponsors to show how our wide range of...

Ask the Experts about about the role...

Some of the world’s leading experts will take part in an outstanding symposium...

Mölnlycke Health Care acquires innovative...

Mölnlycke Health Care announces that it has acquired a pioneering electrical...

Mölnlycke Health Care Wound care - Exhibits...

Mölnlycke Health Care will take part in World Union of Wound Healing Societies...

Molnlycke.com now offers even more knowledge...

We are proud to present “Ask the experts”, the latest feature in the Knowledge...

Join us or follow us online during WUWHS...

We look forward to meeting you at the World Union of Wound Healing Societies...

Dr Evan Call on the difference between...

On the 3rd of September Mölnlycke Health Care, together with some of the...

Wendy White on the topic pain as a universal...

On the 5th of September Mölnlycke Health Care, together with some of the...

Mepilex Border Heel

  // The well established and highly successful product range of Mepilex® Border continues to grow...

Do you know about Stop Pressure Ulcer...

This annual day aims to raise awareness of the global burden of pressure...

Stop Pressure Ulcers

Did you know that Stop Pressure Ulcer Awareness Day is happening this Friday 16 November? This...

EWMA pressure ulcer symposium report:...

The EWMA delegates who attended the Mölnlycke Health Care seminar on pressure...

Mepilex Transfer Ag

The efficacy of wound contact layer dressings with antimicrobial properties in clinical wound care...

Mepilex Border Post-Op

The need for a reliable, surgically safe post-operative wound dressing for both clinical and patient...

Introducing Mepilex Border Flex

The Mepilex® Border product range has just become more versatile than...

Mölnlycke Health Care welcomes you to...

Every day we will "share our care" by presenting you different views on...

Construction matters: The use of multilayer...

During this year's World Union congress in Yokohama, Japan C Tod Brindle...

Mepilex Ag - A key element in wound...

A recently published French study has confirmed the effectiveness of Mepilex®...

EWMA symposium report: Examining how...

Several hundred EWMA delegates attended the Mölnlycke Health Care symposium,...

International DEBRA Congress 2013

Epidermolysis bullosa (EB) is a rare, inherited skin disorder which causes...

Mölnlycke Health Care presents pain...

Mölnlycke Health Care participated in two interesting congresses in Vienna,...

Mölnlycke Health Care proud sponsor...

Mölnlycke Health Care recently had the honour of sponsoring the 2013 DEBRA...

Clinical trial shows dressings have...

Hospital acquired pressure ulcers are a major challenge for medical practitioners....

ISPeW congress 2013

It is approximately one week until the inter-annual  ISPeW meeting in Miami, US. The International...

EWMA 2014

Mölnlycke Health Care has always been creating a legacy of leading the way in wound care management,...

Influencing cost effective wound care

Mölnlycke Health Care has chosen "Leading the way in innovation and evidence"...

Summarizing EWMA 2014 in Madrid

As in previous years, delegates who attended the EWMA 2014 Conference in...

ISBI congress 2014

This month, Mölnlycke Health Care has been attending, hosting dedicated events and been platinum...

EWMA 2015

One of the best showcases for innovation is in the sharing of knowledge and best practices, and...

EWMA 2015 recap

The annual European Wound Management Association (EWMA) event gives Mölnlycke Health Care the opportunity...

GlucanPro 3000 and GlucanPro Cream changing...

Mölnlycke Health Care has announced that it will no longer offer GlucanPro®...

Proven prevention: Proof into practice...

Hospital acquired conditions, such as pressure ulcers, are expensive and,...

Mepilex Border Post-Op wins Health Product...

Mölnlycke Health Care is proud to announce that Mepilex® Border Post-Op has...

New pressure ulcer prevention monograph...

Hospital-acquired conditions are a strategic focus area for Mölnlycke Health...